These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26173191)

  • 1. Modified HAS-BLED Score and Risk of Major Bleeding in Patients Receiving Dabigatran and Rivaroxaban: A Retrospective, Case-Control Study.
    Tsu LV; Berry A; Wald E; Ehrlich C
    Consult Pharm; 2015 Jul; 30(7):395-402. PubMed ID: 26173191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
    Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
    BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study.
    Harel Z; Mamdani M; Juurlink DN; Garg AX; Wald R; Yao Z; Gomes T
    Can J Cardiol; 2016 Aug; 32(8):986.e17-22. PubMed ID: 26992571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Real-World Treatment of Hemorrhages Associated With Dabigatran and Rivaroxaban: A Multicenter Evaluation.
    Pahs L; Beavers C; Schuler P
    Crit Pathw Cardiol; 2015 Jun; 14(2):53-61. PubMed ID: 26102014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection.
    Yoshio T; Tomida H; Iwasaki R; Horiuchi Y; Omae M; Ishiyama A; Hirasawa T; Yamamoto Y; Tsuchida T; Fujisaki J; Yamada T; Mita E; Ninomiya T; Michitaka K; Igarashi M
    Dig Endosc; 2017 Sep; 29(6):686-694. PubMed ID: 28295638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of gastrointestinal bleeding among patients with atrial fibrillation after initiating dabigatran therapy.
    Lauffenburger JC; Rhoney DH; Farley JF; Gehi AK; Fang G
    Pharmacotherapy; 2015 Jun; 35(6):560-8. PubMed ID: 26044889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency admissions for major haemorrhage associated with direct oral anticoagulants.
    Bouget J; Oger E
    Thromb Res; 2015 Dec; 136(6):1190-4. PubMed ID: 26545315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal bleeding risk of non-vitamin K oral anticoagulants is similar to warfarin - a Japanese retrospective cohort study
.
    Shirai T; Yamamoto T; Kawasugi K; Kuyama Y; Kita H
    Int J Clin Pharmacol Ther; 2016 Nov; 54(11):841-846. PubMed ID: 27569738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different risk factors for bleeding and discontinuation between dabigatran and rivaroxaban.
    Nishino M; Okamoto N; Tanaka A; Mori N; Hara M; Yano M; Makino N; Egami Y; Shutta R; Tanouchi J
    J Cardiol; 2016 Aug; 68(2):156-60. PubMed ID: 26443373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RHEDAR study: Determination of the risk of gastrointestinal hemorrhage in treatment with dabigatran, acenocoumarol and rivaroxaban.
    Agudo-Fernández S; Castaño Milla C; González Blanco A; Olmos Jerez JA; Calvo Morillas I; Sancho Del Val L
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2794-2802. PubMed ID: 33978991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
    Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of gastrointestinal bleeding with dabigatran: a head-to-head comparative study with rivaroxaban.
    Sherid M; Sifuentes H; Sulaiman S; Samo S; Husein H; Tupper R; Thiruvaiyaru D; Spurr C; Sridhar S
    Digestion; 2014; 90(2):137-46. PubMed ID: 25278002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
    Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective study about 73 consecutive patients treated by direct oral anticoagulant and admitted to an emergency room].
    Moustafa F; Milhaud G; Dublanchet N; Lebreton A; Dutheil F; Schmidt J
    J Mal Vasc; 2015 Feb; 40(1):1-9. PubMed ID: 25572151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban).
    Lv M; Jiang S; Wu T; Huang N; Chen X; Chen C; Zhang J
    Br J Clin Pharmacol; 2023 Jan; 89(1):253-260. PubMed ID: 35971682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation].
    Gorzelak-Pabiś P; Duraj I; Szlagowska L; Ciastkowska A; Broncel M
    Pol Merkur Lekarski; 2014 Nov; 37(221):261-4. PubMed ID: 25546985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
    Lip GY; Frison L; Halperin JL; Lane DA
    J Am Coll Cardiol; 2011 Jan; 57(2):173-80. PubMed ID: 21111555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.